IDF’s translational research programme sees surge in applications

The 4th round of funding for IDF’s BRIDGES (Bringing Research in Diabetes to Global Environments and Systems) programme came to a close on February 15.

Dedicated to short term projects worth up to USD 65.000 and covering a maximum of two years, the round saw an over 200% increase in applicants from last year’s 3rd round.

“The increase in applications shows how critical translational research is for communities all over the world” said Professor Linda Siminerio, Chair of BRIDGES Executive Committee, “the chance to learn from one another in an effort to counteract the diabetes epidemic and improve the everyday lives of people with diabetes is priceless”.

Applications came from all seven IDF regions. The top three applicant countries are India, China and the USA.

Each application will now be independently reviewed by a group of international experts and the final selection announced at the end of March.

Now supporting 29 projects in 24 countries, BRIDGES is an IDF programme supported by an educational grant from Lilly Diabetes. The programme funds translational research projects in primary and secondary prevention of diabetes to provide the opportunity to ‘translate’ lessons learned from clinical research to those who can benefit most: people affected by diabetes.

For more information on BRIDGES projects, check out the BRIDGES Activity Report.